Aurora Cannabis Posts Billion Dollar Loss In Q3, To Close Edmonton Facility

Aurora Cannabis (TSX: ACB) reported another quarter to remember last night as it continues to slash its operations in an attempt to reach profitability. At the same time, the company saw its revenue decline roughly 17% on a sequential basis as it continues to lose market share.

Revenue for the fiscal third quarter came in at $50.4 million on a net basis, down from $60.6 million seen in the fiscal second quarter. The decline was most significant in the firms consumer cannabis segment, which saw revenue fall 28% from $14.4 million to $10.3 million. Medical revenue meanwhile tumbled only 14%, dropping from $45.7 million to $39.4 million on a quarter over quarter basis.

And things got no better from here.

Cost of sales for the quarter came in at $60.4 million, putting the company into gross loss territory before fair value adjustments, with gross losses hitting $10.0 million. Operating expenses meanwhile outstripped gross revenues at $58.2 million, lead by general and administrative expenses of $23.7 million and sales and marketing expenses of $15.9 million. Loss from operations overall totaled $72.4 million.

Other expenses then added to the disaster of a quarter, with the company seeing total other expenses of $940.0 million. The company during the quarter saw impairments of property, plant and equipment of $176.1 million, which was largely the result of the closure of its Aurora Sky facility in Edmonton. To this end, the company is reworking its focus to lower volume higher margin cannabis, which did not fit with the Edmonton operation.

A further $741.7 million in goodwill was impaired during the quarter, leading to the massive loss.

As a result, the company overall posted a net loss for the quarter of $1,012.2 million, while adjusted EBITDA was reported as being negative $12.3 million.

The company meanwhile reported a cash position of $429.9 million, up from $332.4 million, and total current assets of $696.8 million. Total current liabilities meanwhile are sitting at $119.1 million.

In terms of outlook, the company maintains it is on track to “achieving a positive Adjusted EBITDA run rate by the first half of fiscal 2023,” despite the gross loss posted during the quarter. The company has increased the planned cuts to its operation, from $60 to $80 million to that of $150 to $170 million.

Aurora Cannabis last traded at $3.15 on the TSX.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization unless otherwise mentioned. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Aurora Cannabis Looks To Raise US$125 Million Via Bought Deal

Aurora Cannabis (TSX: ACB) (NYSE: ACB) seemingly can’t resist returning to the market when financings...

Thursday, January 21, 2021, 07:46:29 PM

Aurora Cannabis Files US$500 Million Base Shelf Prospectus, Reveals ATM Largely Complete

Aurora Cannabis (TSX: ACB) (NYSE: ACB) appears to be in need of money again. The...

Tuesday, October 27, 2020, 12:07:15 AM

Aurora Cannabis Lists Sun Facility For Sale With Colliers

Aurora Cannabis (TSX: ACB) (NYSE: ACB) has placed its Aurora Sun facility, located in Medicine...

Friday, March 12, 2021, 10:31:43 AM

BMO Struggling to Sell Aurora Cannabis’ TGOD Shares

Last night the Globe and Mail reported that a group of Investment Banks led by...

Friday, September 6, 2019, 12:24:09 AM

Opinion: Cannabis Companies – Reprice Your Employees’ Options

In the run-up to the legalization of adult-use cannabis, cannabis companies across Canada rapidly expanded...

Sunday, March 8, 2020, 10:58:40 AM